FDA Hears Experience Of Regional Device Safety Registries
This article was originally published in The Gray Sheet
Executive Summary
FDA is soliciting ideas from regional programs that gather postmarket data to help design its proposed "Sentinel Network" for medical product safety information
You may also be interested in...
NEJM Editorialists: Sentinel System Feasible, But Presents Challenges
FDA's post-market surveillance Sentinel Initiative comes with some steep challenges, several health policy experts write in the New England Journal of Medicine July 27
NEJM Editorialists: Sentinel System Feasible, But Presents Challenges
FDA's post-market surveillance Sentinel Initiative comes with some steep challenges, several health policy experts write in the New England Journal of Medicine July 27
FDA Sentinel Initiative Needs Safeguards To Protect Industry And Patients
A greatly expanded drug and device surveillance program could do more harm than good without proper safeguards in place, according to participants at a Dec. 16 FDA-sponsored workshop